WHC is still in active development. Read this to understand our approach.
depiction of WUTYZMFRCNBCHQ-UHFFFAOYSA-N.svg
isomerdesign

Cevimeline

Verificar en isomerdesign

pubchem

Spiro(1-azabicyclo(2...

Verificar en pubchem

drugmap

Cevimeline

Verificar en drugmap

wiki

Cevimeline

Verificar en wiki

Data

InChI: InChI=1S/C10H17NOS/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11/h8-9H,2-7H2,1H3

Sinónimos: AF-102B,(3S,2'S)-2'-Methylspiro[1-azabicyclo[2.2.2]octane-3,5'-[1,3]oxathiolane], SND-5008, (+/-)-cis-2-methylspiro(1-azabicyclo[2.2.2]octance-3,5'-(1,3)oxathiolane) hydrochloride hemihydrate,NCGC00371104-01, Cevimeline hydrochloride, AF 102B, FKS-508, SNI-2011, (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] hydrate hydrochloride, Cevimeline HCl 1/2H2O,Cevimeline [INN],107233-08-9,CEVIMELINE [WHO-DD], 2-Methyspiro(1,3-oxathiolane-5,3)quinuclidine, Evoxac (TN),SCHEMBL299761, Cevimeline [INN], Saligren, (2R,2'R)-2'-methylspiro[4-azabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] dihydrochloride hydrate, Cevimeline hydrochloride [USAN], Cevimeline hydrochloride hydrate, Cevimeline hydrochloride hydrate (JAN), AF102B,K9V0CDQ56E, Cevimeline.HCl, Cis-2-Methylspiro(1,3-oxathiolane-5,3')quinuclidine hydrochloride hydrate (2:2:1), SNK-508, Cevimeline (INN), Saligren (TN), Fks 508,CEVIMELINE [VANDF], (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] dihydrate hydrochloride, Cevimeline hydrochloride hemihydrate, Cevimeline hydrochloride (USAN),HSDB 7286,UNII-K9V0CDQ56E,CEVIMELINE [MI], (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] hydrate dihydrochloride,Fks 508,Spiro(1-azabicyclo(2.2.2)octane-3,5'-(1,3)-oxathiolane), 2'-methyl-, cis-,ZINC8699,Evoxac,Cevimeline, SND 5008, AF-102B, FKS-508, AF-102B, (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane],CEVIMELINE [HSDB],AKOS006327909,SPIRO(1-AZABICYCLO(2.2.2)OCTANE-3,5'-(1,3)OXATHIOLANE), 2'-METHYL-, (+-)-cis-2-Methylspiro(1,3-oxathiolane-5,3'-quinuclidine) hydrochloride, hemihydrate


Estimated data

Solubilidad: -1.248 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 44.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.